TON - Daily

The majority of patients 70 years or older with acute myeloid leukemia (AML) have a poor prognosis and may not benefit from intensive chemotherapy, a study by M. D. Anderson Cancer Center researchers indicates.
 
Page 72 of 72
Results 711 - 711 of 711